WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010137022) GPR54 AGONISTS OR ANTAGONISTS FOR TREATMENT OF DISEASES PRESENTING BEHAVIORAL ABNORMALITIES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/137022    International Application No.:    PCT/IL2010/000422
Publication Date: 02.12.2010 International Filing Date: 27.05.2010
IPC:
A61P 25/18 (2006.01), A61K 38/22 (2006.01)
Applicants: YEDA RESEARCH AND DEVELOPMENT CO. LTD [IL/IL]; Weizmann Institute of Science P.O. Box 95 76100 Rehovot (IL) (For All Designated States Except US).
EISENBACH-SCHWARTZ, Michal [IL/IL]; (IL) (For US Only).
LEWITUS, Gil M [IL/IL]; (IL) (For US Only).
CARDON-YAAKOV, Michal [IL/IL]; (IL) (For US Only).
RON-HAREL, Noga [IL/IL]; (IL) (For US Only)
Inventors: EISENBACH-SCHWARTZ, Michal; (IL).
LEWITUS, Gil M; (IL).
CARDON-YAAKOV, Michal; (IL).
RON-HAREL, Noga; (IL)
Agent: BEN-AMI & ASSOCIATES; P.O. Box 94 76100 Rehovot (IL)
Priority Data:
61/181,422 27.05.2009 US
Title (EN) GPR54 AGONISTS OR ANTAGONISTS FOR TREATMENT OF DISEASES PRESENTING BEHAVIORAL ABNORMALITIES
(FR) AGONISTES OU ANTAGONISTES DE GPR54 UTILES DANS LE TRAITEMENT DE MALADIES IMPLIQUANT DES ANOMALIES DU COMPORTEMENT
Abstract: front page image
(EN)Use of a GPR54 agonist or antagonist for the treatment of a disease or disorder presenting behavioral abnormalities associated with impairment of sensory gating function, and/or for treatment of depression, and/or for improving cognitive function is disclosed. In particular, the invention relates to the use of kisspeptin or a peptide thereof for the treatment of schizophrenia
(FR)L'invention concerne l'utilisation d'un agoniste ou d'un antagoniste de GPR54 pour traiter une maladie ou un trouble impliquant des anomalies comportementales associées à une déficience de la fonction de filtrage sensoriel et/ou traiter la dépression et/ou améliorer la fonction cognitive. L'invention concerne en particulier l'utilisation de la kisspeptine ou d'un peptide de celle-ci pour traiter la schizophrénie.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)